• An Early-Stage THx, Dx & Device Focus:

    Welcome to the site formerly known as [Colorado] Life Science Deal Flow. This new version looks at the biopharma world primarily from an early-stage financing perspective. Be certain to visit our companion site, a FREE Venture Capital dBase, OnBioVC.com, and subscribe by email or RSS.
  • SEARCH the Life Science Deal Flow ARCHIVE

  • business strategy life science

Good stuff here. The first ~seven minutes are intro, then comes a variety of introductory concepts related to Terms in the Term Sheet. Considering these are tech investors I thought they could do a better job with displaying the spreadsheet, but that is being knit-picky. Grab a cup of yerba mate and enjoy…

Click [HERE] to [...]

If you have not been paying attention lately, perhaps this will jar something loose…$1BILLION IN CASH GRANTS AVAILABLE FOR EMERGING LIFE SCIENCE COMPANIES aka Section 48D of the IRS code “The Qualifying Therapeutic Discovery Project Credit”. That get your attention? Good. The recently enacted healthcare reform legislation provides up to $1 billion in tax credits [...]

Contribute to the Conversation at the:
Job Creation and Entrepreneurship Forum
University of Denver, The Chambers Center, the Garden Room
Friday, May 14th, 2010
2:30 pm-5:00 pm
How do we create the jobs of the 21st century? How do we create the right environment for the next generation of entrepreneurs? Creating the companies and jobs of the 21st century will [...]

Hello Friends and Colleagues. Here is an event you are not going to want to miss. Admission is ***FREE*** but seats are limited! Please RSVP at http://GoldLabSymposium.com
2010 GoldLab Symposium – Time: The Crucial Fourth Dimension of Personalized Medicine
GoldLab announces the upcoming GoldLab Inaugural Symposium 2010–Time: The Crucial Fourth Dimension of Personalized Medicine scheduled for Friday, [...]

Hot off the press! The 1Q10 OnBioVC Trend Analysis study is available for download [HERE]; and now features OnBioIPO and OnBioM&A data too!
The 1Q10 OnBioVC Trend Analysis tracked, in aggregate, 74 biopharma, diagnostic, device, medical-IT and biofuel venture financings totaling $1,260.1M. Compared to 1Q09 OnBioVC data, this investment activity represents a decrease in the number [...]

So based upon the recent ruling of Myriad Genetics (NASDAQ: MYGN) invalidation of certain patents covering the BRCA1 and BRCA2 genes, I was planning on levering the news as fodder for an all out April Fools’ post effort, likely to have been something along the lines of ‘10,000 Gene-based Patents Overturned, Biotechnology Industry Implodes’. [...]

The 2010 Season of BioBeers kicks-off on Tuesday 2 March 6:30pm. This is not your mother’s, uncle’s, brother’s BioBeers. The format has been re-engineered with the hope that you will find attending the Meetups more valuable than ever. But it takes a village to make BioBeers, that is why I urge you to visit http://www.BioBeers.com [...]

The folks over at Deloitte are not so subtly pounding the drum about inevitable and dramatic change coming in life science sales methodologies – and are providing a rationale as to why pharma should in fact “blow up” the current sales force model. This is an important thesis to consider particularly if your entity is [...]

OnBioVC.com – the sister site to Life Science Deal Flow – has released the 3Q09 Trend Analysis, the .pdf can be downloaded [HERE].

Over $1,663M flowed into early-stage biopharma, diagnostic and device companies in the third quarter of 2009 and over $4,806M year-to-date!

Headquartered in Boulder, Colorado, OnBioVC provides timely coverage and comprehensive analysis of global bioscience [...]

[Update #2] A bold call? Perhaps… As 2009 winds down with about ten weeks to go it sounds as if one should not be surprised that large stockpiles of cash move from the sideline, tighten the chinstrap and get in the game – from limited partners to funds to institutions – who move to [...]

Recall that Steven Dow, DVM, Ph.D., Professor in the departments of Clinical Sciences and Pathology in the College of Veterinary Medicine at Colorado State University, co-founded Juvaris Biotherapeutics.
Good or bad, Juvaris is now a Burlingame, CA-based biotechnology company, developing adjuvanted vaccines for infectious diseases. Recently a definitive agreement with Antigen Discovery, Inc. was announced [...]

Welcome to WordPress. This is your first post. Edit or delete it, then start blogging!

Do you plan to attend BIO in two weeks? If so be certain to attend the Colorado pre-conference networking reception on 10 June 5:00 – 6:30pm at the Governor’s Mansion Carriage House. Be certain to RSVP if you are planning to attend, contact Becky Chandler 303.892.3707 or becky.chandler@state.co.us. We can thank the Colorado Bio Science [...]

« Previous Entries  Next Page »

to top of page...


 
  • The Latest LSDF Activity

    July 2010
    M T W T F S S
    « May    
     1234
    567891011
    12131415161718
    19202122232425
    262728293031  
  • Search the LSDF Archive

  • Your Advert Can Go Here!

    Find out how, email: arubenstein@rnaventures.com